|
|
|
|
| LEADER |
01276cam a2200409 4500 |
| 001 |
PPN011998040 |
| 005 |
20210712055700.0 |
| 010 |
|
|
|a 0-471-94058-5
|
| 020 |
|
|
|a US
|b 946104
|
| 020 |
|
|
|a GB
|b 94-70670
|
| 035 |
|
|
|a sib0661482
|
| 035 |
|
|
|a ocm29912261
|
| 100 |
|
|
|a 19951023d1994 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a a z 001yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a Pharmacoepidemiology
|b Texte imprimé
|f ed. by Brian L. Strom
|
| 205 |
|
|
|a 2nd ed
|
| 210 |
|
|
|a Chichester
|a New York
|c John Wiley and sons
|d 1994
|
| 215 |
|
|
|a 1 vol. (XVIII-741 p.)
|c ill.
|d 26 cm
|
| 320 |
|
|
|a Notes bibliogr. Index
|
| 606 |
|
|
|3 PPN027578712
|a Médicaments
|x Effets secondaires
|2 rameau
|
| 606 |
|
|
|3 PPN027731456
|a Épidémiologie
|3 PPN027315754
|x Recherche
|2 rameau
|
| 606 |
|
|
|3 PPN027338398
|a Pharmacovigilance
|2 rameau
|
| 606 |
|
|
|3 PPN04082540X
|a Pharmacoépidémiologie
|2 fmesh
|
| 676 |
|
|
|a 615/.704
|v 20
|
| 680 |
|
|
|a RM302.5
|b .P53 1994
|
| 686 |
|
|
|a QZ 42
|b P536 1994
|2 usnlm
|
| 702 |
|
1 |
|3 PPN050467514
|a Strom
|b Brian L.
|4 340
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20070404
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 930 |
|
|
|5 441092101:303936371
|b 441092101
|a QZ 42 STR
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 150455
|
Nantilus
